Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04945746 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dispersion Stability

StatusUnknown
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Changed Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting
  2. Trial status: Suspended to Active, Not Recruiting
    • Study completion date: Jan 28, 2024 to Jan 28, 2025
    v3
  3. Trial status: Not Yet Recruiting to Suspended Sponsor's reason: technical problem with VX1 softwarev2 Show 4 more changesShow less
    • Primary completion date: Oct 28, 2021 to Oct 28, 2023
    • Study sites: 0 to 1
    • Study completion date: Jan 28, 2022 to Jan 28, 2024
    • Start date changed from estimate of Jun 28, 2021 to Aug 5, 2021
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To assess the acute efficacy of ablation of the most stable VX1 areas (levels 2 and 3) in terms of the rate of acute AF termination. Identify the spatial distribution of dispersion stability levels based on VX1. Document the rate of adverse events. To assess the long-term efficacy of ablation of the most stable VX1 areas in terms of the absence of documented arrhythmias during a 12-month follow-up.
Trial Details
NCT Number NCT04945746
Lead Sponsor Hospital St. Joseph, Marseille, France
Conditions
(from sponsor)		 Atrial Fibrillation
Related terms Atrial Fibrillation
Enrollment 35 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov